The first installation in France of ZAP-X, the latest innovation in the treatment of malignant and benign intracranial tumors by radiosurgery, is underway at the Porte de Saint-Cloud Cancer Center.
All the Verso Healthcare teams are proud to have participated in providing the patients of this center very soon with a non-invasive, painless outpatient treatment allowing them to return to normal life the same day.
123CS, a subsidiary of the Verso Healthcare group, is honored at the start of the year by the specialized media GRC Viewpoint. The opportunity for Laurent DERTIN, Director of 123CS and expert, to come back
The first installation in France of ZAP-X, the latest innovation in the treatment of malignant and benign intracranial tumors by radiosurgery, is underway at the Porte de Saint-Cloud Cancer Center. All the Verso Healthcare teams
To support the group’s strong commitments and growth at the international level, Verso Healthcare is pleased to announce that David DESPRETZ is joining the group as Chief Commercial Officer, reporting directly to the Group Chairman.
After having been awarded in 2021, the ExpertCyber label delivered by the French State, 123CS has just joined the Alliance for Digital Confidence (ACN) and obtained the ECSO Cybersecurity Made in Europe label. The Alliance
New article on Hospitalia: 2022 has only been around for a few weeks, but it is already shaping up to be a year at the crossroads of several issues for the world of healthcare. Verso
Qualimedis and Verso Healthcare are facilitating access to ViewRay®’s MRIdian™ Linac system, the world’s first and only MRI-guided system for adaptive radiotherapy, with real-time monitoring synchronised with radiation delivery. It is a major example of
123CS, a subsidiary of the Verso Healthcare group, is honored at the start of the year by the specialized media GRC Viewpoint. The opportunity for Laurent DERTIN, Director of 123CS and expert, to come back
The first installation in France of ZAP-X, the latest innovation in the treatment of malignant and benign intracranial tumors by radiosurgery, is underway at the Porte de Saint-Cloud Cancer Center. All the Verso Healthcare teams
To support the group’s strong commitments and growth at the international level, Verso Healthcare is pleased to announce that David DESPRETZ is joining the group as Chief Commercial Officer, reporting directly to the Group Chairman.
After having been awarded in 2021, the ExpertCyber label delivered by the French State, 123CS has just joined the Alliance for Digital Confidence (ACN) and obtained the ECSO Cybersecurity Made in Europe label. The Alliance
New article on Hospitalia: 2022 has only been around for a few weeks, but it is already shaping up to be a year at the crossroads of several issues for the world of healthcare. Verso
